These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 15693960)

  • 21. Drotrecogin alfa (activated) for nonmenstrual toxic shock syndrome associated with methicillin resistant Staphylococcus aureus infection.
    Haddadin DW; Samnani IQ; Moorman JP
    South Med J; 2006 Nov; 99(11):1295-6. PubMed ID: 17195430
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cardiovascular management of septic shock.
    Dellinger RP
    Crit Care Med; 2003 Mar; 31(3):946-55. PubMed ID: 12627010
    [No Abstract]   [Full Text] [Related]  

  • 23. Assessing the effect of the Surviving Sepsis Campaign treatment guidelines on clinical outcomes in a community hospital.
    Patel GW; Roderman N; Gehring H; Saad J; Bartek W
    Ann Pharmacother; 2010 Nov; 44(11):1733-8. PubMed ID: 20978215
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008.
    Dellinger RP; Levy MM; Carlet JM; Bion J; Parker MM; Jaeschke R; Reinhart K; Angus DC; Brun-Buisson C; Beale R; Calandra T; Dhainaut JF; Gerlach H; Harvey M; Marini JJ; Marshall J; Ranieri M; Ramsay G; Sevransky J; Thompson BT; Townsend S; Vender JS; Zimmerman JL; Vincent JL
    Intensive Care Med; 2008 Jan; 34(1):17-60. PubMed ID: 18058085
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A blueprint for a sepsis protocol.
    Shapiro NI; Howell M; Talmor D
    Acad Emerg Med; 2005 Apr; 12(4):352-9. PubMed ID: 15805328
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Current Controversies in Sepsis Management.
    Moss SR; Prescott HC
    Semin Respir Crit Care Med; 2019 Oct; 40(5):594-603. PubMed ID: 31826260
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Sepsis update: management of severe sepsis and septic shock in the emergency department after the withdrawal of Xigris.
    Green RS; Djogovic D; Howes D
    CJEM; 2012 Sep; 14(5):265-9. PubMed ID: 22967692
    [No Abstract]   [Full Text] [Related]  

  • 28. The role of bundles in sepsis care.
    Hurtado FJ; Nin N
    Crit Care Clin; 2006 Jul; 22(3):521-9, x. PubMed ID: 16893737
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Time- and fluid-sensitive resuscitation for hemodynamic support of children in septic shock: barriers to the implementation of the American College of Critical Care Medicine/Pediatric Advanced Life Support Guidelines in a pediatric intensive care unit in a developing world.
    Oliveira CF; Nogueira de Sá FR; Oliveira DS; Gottschald AF; Moura JD; Shibata AR; Troster EJ; Vaz FA; Carcillo JA
    Pediatr Emerg Care; 2008 Dec; 24(12):810-5. PubMed ID: 19050666
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [A new drug which saves lives. Sepsis: chaos in the body--recent aspects of pathophysiology and therapy].
    Haas I
    Krankenpfl J; 2002; 40(10-12):310-4. PubMed ID: 12600015
    [No Abstract]   [Full Text] [Related]  

  • 31. Human recombinant protein C for severe sepsis and septic shock in adult and paediatric patients.
    Martí-Carvajal AJ; Solà I; Gluud C; Lathyris D; Cardona AF
    Cochrane Database Syst Rev; 2012 Dec; 12(12):CD004388. PubMed ID: 23235609
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Management of sepsis during the early "golden hours".
    Raghavan M; Marik PE
    J Emerg Med; 2006 Aug; 31(2):185-99. PubMed ID: 17044583
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Septic shock--evaluating another failed treatment.
    Wenzel RP; Edmond MB
    N Engl J Med; 2012 May; 366(22):2122-4. PubMed ID: 22616829
    [No Abstract]   [Full Text] [Related]  

  • 34. Sepsis Care Pathway 2019.
    Labib A
    Qatar Med J; 2019; 2019(2):4. PubMed ID: 31763206
    [No Abstract]   [Full Text] [Related]  

  • 35. Severe sepsis and septic shock: review of the literature and emergency department management guidelines.
    Nguyen HB; Rivers EP; Abrahamian FM; Moran GJ; Abraham E; Trzeciak S; Huang DT; Osborn T; Stevens D; Talan DA;
    Ann Emerg Med; 2006 Jul; 48(1):28-54. PubMed ID: 16781920
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Drotrecogin alpha (activated) in septic shock after lung transplant.
    Feltracco P; Rea F; Ori C
    J Heart Lung Transplant; 2008 Jul; 27(7):815. PubMed ID: 18582817
    [No Abstract]   [Full Text] [Related]  

  • 37. Dexamethasone and recombinant human activated protein C improve myocardial function and efficiency during experimental septic shock.
    Lemarie J; Blet A; Bouazza Y; Boisrame-Helms J; Meziani F; Levy B
    Shock; 2014 Jun; 41(6):522-7. PubMed ID: 24837202
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [On activated protein C in septic shock].
    Offenstadt G
    Presse Med; 2006 Jun; 35(6 Pt 1):989; author reply 989. PubMed ID: 16783262
    [No Abstract]   [Full Text] [Related]  

  • 39. "All in" for a huge pot: the PROWESS-SHOCK trial for refractory septic shock.
    Barie PS
    Surg Infect (Larchmt); 2007 Oct; 8(5):491-4. PubMed ID: 17999581
    [No Abstract]   [Full Text] [Related]  

  • 40. The Impact of the Sepsis-3 Septic Shock Definition on Previously Defined Septic Shock Patients.
    Sterling SA; Puskarich MA; Glass AF; Guirgis F; Jones AE
    Crit Care Med; 2017 Sep; 45(9):1436-1442. PubMed ID: 28542029
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.